Michael Nebozhyn
- Oncology top 0.5%
- Immunology top 1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 2%
- Co-authors
- Andrey LobodaMark AyersJared LuncefordAndrew AlbrightErin MurphyJennifer H. YearleyAntoni RibasJonathan D. Cheng
- Topics
- Cancer Immunotherapy and Biomarkers (20 papers)Colorectal Cancer Treatments and Studies (15 papers)Cancer Genomics and Diagnostics (14 papers)
- Cited by
- OncologyImmunologyCancer Research
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Michael Nebozhyn
60 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Oncology 3.0k
- Immunology 1.6k
- Molecular Biology 1.6k
- Pulmonary and Respiratory Medicine 1.1k
- Cancer Research 998
Countries citing papers authored by Michael Nebozhyn
This map shows the geographic impact of Michael Nebozhyn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Nebozhyn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Nebozhyn more than expected).
Fields of papers citing papers by Michael Nebozhyn
This network shows the impact of papers produced by Michael Nebozhyn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Nebozhyn. The network helps show where Michael Nebozhyn may publish in the future.
Co-authorship network of co-authors of Michael Nebozhyn
This figure shows the co-authorship network connecting the top 25 collaborators of Michael Nebozhyn. A scholar is included among the top collaborators of Michael Nebozhyn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Nebozhyn. Michael Nebozhyn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 3 | |
| 3 | 1 | |
| 4 | 8 | |
| 5 | 3 | |
| 6 | 19 | |
| 7 | 40 | |
| 8 | 27 | |
| 9 | 96 | |
| 10 | 16 | |
| 11 | 152 | |
| 12 | 30 | |
| 13 | 73 | |
| 14 | 24 | |
| 15 | 1 | |
| 16 | 58 | |
| 17 | 283 | |
| 18 | 13 | |
| 19 | 50 | |
| 20 | 31 |
About Michael Nebozhyn
Michael Nebozhyn is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 62 papers that have together received 5.1k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Colorectal Cancer Treatments and Studies (15 papers) and Cancer Genomics and Diagnostics (14 papers). The work is most often cited by research in Oncology (3.0k citations), Immunology (1.6k citations) and Cancer Research (998 citations). Michael Nebozhyn has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Andrey Loboda, Mark Ayers, Jared Lunceford, Andrew Albright, Erin Murphy, Jennifer H. Yearley, Antoni Ribas, Jonathan D. Cheng, Terrill K. McClanahan and Tanguy Y. Seiwert. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.